Vimarsana
Biggest News Aggregation in the World

Page 2 - Codexis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Codexis Inc Today - Breaking & Trending Today

Codexis: Q1 Earnings Snapshot - Vimarsana News

Codexis: Q1 Earnings Snapshot

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Codexis Inc. (CDXS) on Thursday reported a loss of $11.5 million in its first quarter.

With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns - Vimarsana News

With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns

Key Insights Given the large stake in the stock by institutions, Codexis' stock price might be vulnerable to their...

Source: yahoo.com
Codexis to Report First Quarter 2024 Financial Results on May 2 - Vimarsana News

Codexis to Report First Quarter 2024 Financial Results on May 2

REDWOOD CITY, Calif., April 18, 2024 -- Codexis, Inc. , a leading enzyme engineering company, today announced that it will report its financial results for the first quarter of 2024 on Thursday,...

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory - Vimarsana News

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory

Cobb adds RNA industry operations and commercial expertise to support continued development of ECO Synthesis™ manufacturing platform...

Codexis, Inc. (NASDAQ:CDXS) Given Average Recommendation of "Moderate Buy" by Brokerages - Vimarsana News

Codexis, Inc. (NASDAQ:CDXS) Given Average Recommendation of "Moderate Buy" by Brokerages

Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among analysts that have […]